← Back to guidelines
Hematology1 paper

Nodular lymphoma

Last edited: 4/10/2026

Overview

Calvarial lymphoma is a rare condition that can mimic central nervous system diseases due to its presentation and imaging findings 1. The most common presentation is a subcutaneous scalp mass 1.

Diagnosis

  • Subcutaneous scalp mass (89%), headaches (26%), and focal neurological deficits (21%) are common presentations 1.
  • Osteolytic changes on computed tomography are seen in 69% of patients, with extension into the intracranial or extracranial space in 97% 1.
  • Calvarial lymphoma should be considered in the differential diagnosis of a progressively enlarging scalp mass 1.
  • Management

  • Surgical excision was performed in 41 patients, achieving an 85% remission rate and a 5% recurrence rate 1.
  • Non-surgical treatment resulted in a 75% remission rate and 0% recurrence rate, with no significant difference compared to surgical treatment 1.
  • Treatment approaches have included variable use of surgery plus adjuvant chemotherapy and radiation 1.
  • Key Recommendations

  • Calvarial lymphoma should be considered in the differential diagnosis of a progressively enlarging scalp mass 1. (Evidence: Moderate)
  • Surgical excision may be considered for calvarial lymphoma, with reported remission rates of 85% and recurrence rates of 5% 1. (Evidence: Moderate)
  • Non-surgical management has shown comparable remission rates (75%) and recurrence rates (0%) to surgical intervention 1. (Evidence: Moderate)
  • References

    1 Toyota E, Taslimi S, Alkins R. Optimal Management of Calvarial Lymphoma: A Meta-Analysis. World neurosurgery 2021. link

    Original source

    1. [1]
      Optimal Management of Calvarial Lymphoma: A Meta-Analysis.Toyota E, Taslimi S, Alkins R World neurosurgery (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG